Stock Events

Stock Events

TransCode Therapeutics (RNAZ) Q4 2024 Earnings

Nov 14Confirmed

Q4 2022

Q2 2024

Q3 2024

Q4 2024

-16.17

-10.78

-5.39

0

Details

Expected EPS

-16.17

Actual EPS

-5.28

Surprise EPS

10.89

Surprise Percent

+67.35%

Description

⁨TransCode Therapeutics⁩ (⁦RNAZ⁩) has reported earnings of ⁦-5.28⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.